🇺🇸 NBIX — Neurocrine Biosciences, Inc.

Salud Compra fuerte
← Volver

Precio actual

164,63 USD

Máx. histórico

185,50

99 días

Caída desde máximo

-11,25%

Rango 52 semanas

122,14 – 186,12

Variación hoy

+3,05%

Cierre anterior

159,76

Rango de hoy

158,66 – 165,86

Volumen hoy

1.507.456

Peor caída histórica

-97,21%

15/03/2006 → 12/11/2009

Recuperado en 2911 días

Volatilidad anualizada ⓘ

61,30%

Información
Nombre completo
Neurocrine Biosciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
2.500
PER ⓘ
24,43 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
207,50 USD (puede no estar actualizado)
Primera cotización
23/05/1996
Precio actualizado
hace 21 horas
Sobre la empresa

Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; Orilissa tablets for endometriosis; Oriahnn capsules to treat uterine fibroids; and CRENESSITY to treat congenital adrenal hyperplasia, as well as offers products under the name of ALKINDI and Efmody. Its product candidates in clinical development includes NBI-1076986 to treat movement disorders; Osavampator for inadequate response to treatment in major depressive disorder; NBI-1117568 for the treatment of schizophrenia and bipolar mania; NBI-1117567 for the treatment of Alzheimer's disease; NBI 921355 for the treatment of epilepsy; NBIP-01435 for the treatment of congenital adrenal hyperplasia; NBIP-2118 for the treatment of obesity and related metabolic diseases; and NBI-1070770 to treat major depressive disorder; and NBI-1117570, NBI-1117567, NBI-1117569, NBI-1140675, and NBI-1065890 for neuropsychiatric and neurological conditions. The company also has license and collaboration agreements with Nxera Pharma UK Limited; Takeda Pharmaceutical Company Limited; Xenon Pharmaceuticals Inc.; Voyager Therapeutics, Inc.; Sanofi S.A.; Tanabe Pharma Corporation; and AbbVie Inc. The company was incorporated in 1992 and is headquartered in San Diego, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
13/08/2018 118,24 119,45 115,72 115,84 -2,21% 3,15% 712.600
10/08/2018 118,59 120,83 118,15 118,46 -0,75% 2,26% 472.900
09/08/2018 119,87 120,90 118,49 119,36 +2,14% 2,01% 850.500
08/08/2018 117,25 118,34 116,32 116,86 -0,37% 1,72% 380.300
07/08/2018 117,39 118,23 116,23 117,29 +1,21% 1,70% 577.600
06/08/2018 116,40 118,11 115,03 115,89 -0,10% 2,65% 665.100
03/08/2018 115,85 117,78 114,79 116,01 +0,28% 2,58% 556.100
02/08/2018 114,07 117,91 113,27 115,69 +1,88% 4,07% 1.531.400
01/08/2018 106,25 116,91 104,67 113,55 +13,00% 11,52% 2.986.400
31/07/2018 98,62 100,95 97,19 100,49 +1,51% 3,81% 959.800
30/07/2018 107,00 107,36 98,28 99,00 -7,68% 8,49% 1.386.600
27/07/2018 108,36 108,80 104,39 107,23 -0,79% 4,07% 555.400
26/07/2018 107,47 109,14 106,47 108,08 +0,00% 2,48% 696.200
25/07/2018 105,80 109,15 105,50 108,08 +2,21% 3,45% 805.000
24/07/2018 105,14 107,57 104,76 105,74 +1,87% 2,67% 1.353.200
23/07/2018 103,53 105,36 102,96 103,80 +0,36% 2,32% 471.700
20/07/2018 104,15 105,24 103,19 103,43 -0,37% 1,97% 510.200
19/07/2018 103,15 104,28 101,94 103,81 +0,57% 2,27% 335.400
18/07/2018 104,81 104,85 102,30 103,22 -1,26% 2,43% 458.500
17/07/2018 101,10 105,33 99,86 104,54 +3,16% 5,41% 664.600
16/07/2018 103,23 103,61 99,66 101,34 -1,51% 3,83% 585.600
13/07/2018 102,56 103,53 101,80 102,89 +0,10% 1,69% 290.900
12/07/2018 102,16 102,98 101,65 102,79 +1,37% 1,30% 358.300
11/07/2018 102,08 102,20 100,31 101,40 -1,28% 1,85% 460.500
10/07/2018 103,29 103,72 102,09 102,71 -0,10% 1,58% 455.300
09/07/2018 103,08 104,75 101,60 102,81 +0,35% 3,06% 413.500
06/07/2018 99,00 102,62 99,00 102,45 +3,61% 3,66% 463.200
05/07/2018 99,35 99,94 97,34 98,88 -0,22% 2,62% 865.000
03/07/2018 99,43 100,88 98,75 99,10 -0,18% 2,14% 322.000
02/07/2018 97,58 99,75 96,98 99,28 +1,06% 2,84% 449.700